Examining the use of salpingectomy with hysterectomy in Canada

Current Oncology

Volumn 20, Issue 3, 2013, Pages 173-175

  Sandoval, C ^a   Fung Kee Fung, M ^b   Gilks, B ^c   Murphy, K J ^d   Rahal, R ^a   Bryant, H ^a,e  

^a Canadian Partnership Against Cancer   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; HYSTERECTOMY; INTERVENTION STUDY; NOTE; OVARY CANCER; PATIENT MONITORING; RISK REDUCTION; SALPINGECTOMY;

EID: 84878766925     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.20.1560     Document Type: Note

References (8)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian Cancer Statistics 2012. Toronto, ON: Canadian Cancer Society; 2012.
2. Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 2009;19:58-64.
3. Tone AA, Salvador S, Finlayson SJ, et al. The role of the fallopian tube in ovarian cancer. Clin Adv Hematol Oncol 2012;10:296-306.
4. The Society of Gynecologic Oncologists of Canada (GOC). GOC Statement Regarding Salpingectomy and Ovarian Cancer Prevention. Ottawa, ON: GOC; 2011. [Available online at: http://www.g-o-c.org/uploads/11sept15_gocevidentiarystatement_final_en.pdf; cited February 11, 2013]
5. Dietl J, Wischhusen J, Häusler SF. The post-reproductive Fallopian tube: better removed? Hum Reprod 2011;26:2918-24.
6. Greene MH, Mai PL, Schwartz PE. Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 2011;204:19.e1-6.
7. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80-7.
8. Kwon JS, Tinker A, Pansegrau G, et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 2013;121:14-24.